Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing

In this article, we will be taking a look at the 7 Hot Healthcare Stocks to Buy Right Now. Qiagen N.V. is placed seventh among them.

Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, continues to advance its position in clinical laboratories, biopharmaceuticals, and life science research. Headquartered in the Netherlands and operating in over 30 countries under CEO Thierry Bernard, the company provides a wide range of solutions, including nucleic acid extraction systems, PCR reagents, digital PCR platforms, next-generation sequencing kits, and proteomics tools. The company stands seventh on our list among the hot stocks to buy.

In Q2 2025, Qiagen N.V. (NYSE:QGEN) reported net sales of $534 million, marking a 7% increase from the prior year, with an adjusted operating income margin of 29.9%, up 1.5 percentage points. Growth was fueled by strong demand for products such as QIAstat-Dx, which grew 41% CER, and QuantiFERON, which increased 11% CER. Reflecting confidence in its operational momentum, the business raised its full-year 2025 net sales growth outlook to 4–5% CER and reaffirmed its adjusted diluted EPS targets.

Innovation remains central to Qiagen N.V. (NYSE:QGEN)’s strategy. The recent launch of QIAseq xHYB Long Read Panels enhances target enrichment for long-read sequencing platforms, enabling more detailed analysis of complex genomic regions, structural variants, HLA typing, and repeat expansions. Additionally, QGEN continues to expand its digital and automation offerings, with growth in QIAcuity digital PCR systems and the QIAGEN Digital Insights software platform, while preparing to launch three new instruments by late 2025 to strengthen its molecular diagnostics capabilities.

While we acknowledge the potential of QGEN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure. None.